Search
Advertisement
Standard Glass raises Rs 40 crore from Amansa Investment ahead of its IPO

Standard Glass raises Rs 40 crore from Amansa Investment ahead of its IPO

IPO-bound Standard Glass Lining Technology has raised Rs 40 crore via pre-IPO funding from Amansa Investments.

Pawan Kumar Nahar
Pawan Kumar Nahar
  • Updated Dec 23, 2024 12:09 PM IST
Standard Glass raises Rs 40 crore from Amansa Investment ahead of its IPOAs per the DRHP, the IPO of Standard Glass shall include a fresh share sale of Rs 250 crore and offer-for-sale of up to 18,444,000 equity shares.

IPO-bound Standard Glass Lining Technology has raised Rs 40 crore via pre-IPO funding from Amansa Investments. Hyderabad based Standard Glass is a manufacturer of specialized engineering equipment for the pharmaceutical and chemical industries.


As per the company’s public announcement, the company has issued 28,57,142 equity shares to Amansa Investments at a price of Rs 140 per share (including a premium of Rs 130), in consultation with the lead bankers. This transaction, amounting to Rs 40 crore, represents 1.55 per cent of the company’s pre-offer share capital.

Advertisement

Related Articles


Standard Glass had filed its DRHP in July 2024, which stated that its public issue shall include a fresh share sale of Rs 250 crore and offer-for-sale (OFS) of up to 18,444,000 equity shares promoters and other selling shareholders. With the latest round of fundraising, the fresh issue size is likely to be reduced. It received Sebi’s final observation for the IPO in October 2024.


Standard Glass Lining Technology offers comprehensive solutions that encompass design, engineering, manufacturing, assembly, installation, and commissioning, as well as establishing standard operating procedures for pharmaceutical and chemical manufacturers on a turnkey basis.


Its product portfolio includes essential equipment used in the production of pharmaceutical and chemical products, categorized into reaction systems; storage, separation and drying systems; and plant, engineering and services. As of March 31, 2024, the portfolio consisted of more than 65 products and offerings.

Advertisement


The company has 443 customers, including end-users in the pharmaceutical, chemical, paint, biotechnology, and food and beverage sectors including names like Auro Pharma, Cadila Pharma, Deccan Fine Chemicals (India), Laurus Labs, Granules India, Natco Pharma, Piramal Pharma, Suven Pharma among others.


Standard Glass Lining Technology operates eight manufacturing facilities, covering over 400,000 square feet, strategically located in Hyderabad, Telangana. IIFL Securities and Motilal Oswal Investment Advisors are the book-running lead managers, and KFin Technologies is the registrar of the issue.

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Follow us on

ABOUT THE AUTHOR

Pawan Kumar Nahar
Pawan Kumar Nahar

Pawan Nahar is a financial journalist with over a decade in journalism, saying good morning to BSE's Sensex and NSE Nifty50. Keen follower of IPOs, he also tracks cryptos, and personal finance — covering everything one can invest in. Known for due diligence and fluent Hindi, he blends insight with engaging storytelling. A YouTube learner beyond work, he enjoys cooking, poetry, traveling, and gaming.

Published on: Dec 23, 2024 12:09 PM IST